The Biedermann Medtech Groupp’s U.S. operations is undergoing a significant change.

The company will soon expand its focus beyond product distribution to a broader platform of integrated services and solutions designed to reshape its U.S. business model. As part of this transition, Biedermann Motech will no longer directly distribute its spinal and extremity surgery products in the U.S. market. The firm’s decision to discontinue product distribution resulted from a comprehensive and detailed review of market dynamics and recent macro-economic developments.

In the next phase of this transformation, Biedermann Motech will leverage its strategic partnership with Biedermann Technologies to commercialize its substantial U.S. patent and technology portfolio with a next-generation business model. This model will include licensing opportunities for the company’s U.S. spine and extremity product portfolio, patents, and technologies, complemented by a suite of value added services.

Meanwhile, the substantial challenges associated with the European Union’s new Medical Device Regulation (MDR) has led to increased interest in the CE-marked Biedermann spine product portfolio. Consequently, Biedermann Motech will continue to pursue and expand its direct business opportunities outside the United States.

Looking ahead, Biedermann remains committed and continues to push forward and invest, research, innovate, and partner in multiple areas of spinal and extremity surgery, such as advanced less invasive surgery, complex deformity surgery, outpatient ambulatory fusion surgery, cost-efficient procedural solutions, and the integration of next-generation enabling technologies. The company is striving to have a profound and beneficial impact on surgical processes and results, ultimately enhancing patient outcomes inside and outside the United States.

The Biedermann Medtech Group is a mid-sized, family-owned group of companies whose roots date back more than a century (to 1916). Biedermann researches, develops, manufactures, and distributes implant systems in collaboration with healthcare professionals, technology partners, scientific institutions, and specialized companies to achieve improved clinical outcomes. It is also owner and guardian of a patent and technology portfolio for specialized orthopedic markets. For the last 30 years, Biedermann has licensed numerous patents and related technologies to several key players in the orthopedic and neurosurgical field, and established multiple golden standards for spinal technologies.